pH-Triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids.

Acid-decomposable, luminescent ZnO quantum dots (QDs) have been employed to seal the nanopores of mesoporous silica nanoparticles (MSNs) in order to inhibit premature drug (doxorubicin) release. After internalization into HeLa cells, the ZnO QD lids are rapidly dissolved in the acidic intracellular compartments, and as a result, the loaded drug is released into the cytosol from the MSNs. The ZnO QDs behave as a dual-purpose entity that not only acts as a lid but also has a synergistic antitumor effect on cancer cells. We anticipate that these nanoparticles may prove to be a significant step toward the development of a pH-sensitive drug delivery system that minimizes drug toxicity.

[1]  R. Cardiff,et al.  Copper-doxorubicin as a nanoparticle cargo retains efficacy with minimal toxicity. , 2010, Molecular pharmaceutics.

[2]  Jeremy N Skepper,et al.  pH-dependent toxicity of high aspect ratio ZnO nanowires in macrophages due to intracellular dissolution. , 2010, ACS nano.

[3]  Chulhee Kim,et al.  Glutathione‐Induced Intracellular Release of Guests from Mesoporous Silica Nanocontainers with Cyclodextrin Gatekeepers , 2010, Advanced materials.

[4]  J. F. Stoddart,et al.  pH-operated nanopistons on the surfaces of mesoporous silica nanoparticles. , 2010, Journal of the American Chemical Society.

[5]  J. F. Stoddart,et al.  Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by pH-sensitive nanovalves. , 2010, Journal of the American Chemical Society.

[6]  Fuyou Li,et al.  Anticancer drug release from a mesoporous silica based nanophotocage regulated by either a one- or two-photon process. , 2010, Journal of the American Chemical Society.

[7]  J. Fraser Stoddart,et al.  Noninvasive remote-controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles. , 2010, Journal of the American Chemical Society.

[8]  Duncan Graham,et al.  Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin , 2010, Journal of the American Chemical Society.

[9]  Benjamin Gilbert,et al.  Use of a rapid cytotoxicity screening approach to engineer a safer zinc oxide nanoparticle through iron doping. , 2010, ACS nano.

[10]  Taeghwan Hyeon,et al.  Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery. , 2010, Journal of the American Chemical Society.

[11]  L. J. Mueller,et al.  pH-responsive nanogated ensemble based on gold-capped mesoporous silica through an acid-labile acetal linker. , 2010, Journal of the American Chemical Society.

[12]  Q. Ruan,et al.  Dipolar molecules as impellers achieving electric-field-stimulated release. , 2010, Journal of the American Chemical Society.

[13]  J. F. Stoddart,et al.  pH clock-operated mechanized nanoparticles. , 2009, Journal of the American Chemical Society.

[14]  R. Martínez‐Máñez,et al.  Enzyme-responsive controlled release using mesoporous silica supports capped with lactose. , 2009, Angewandte Chemie.

[15]  J. Michaelis,et al.  Nanostructured silica materials as drug-delivery systems for Doxorubicin: single molecule and cellular studies. , 2009, Nano letters.

[16]  Rajesh Singh,et al.  Nanoparticle-based targeted drug delivery. , 2009, Experimental and molecular pathology.

[17]  R. Martínez‐Máñez,et al.  pH- and photo-switched release of guest molecules from mesoporous silica supports. , 2009, Journal of the American Chemical Society.

[18]  T. Bein,et al.  Biotin-avidin as a protease-responsive cap system for controlled guest release from colloidal mesoporous silica. , 2009, Angewandte Chemie.

[19]  Haijiao Zhang,et al.  Nanosized zinc oxide particles induce neural stem cell apoptosis , 2009, Nanotechnology.

[20]  Juan L. Vivero-Escoto,et al.  Photoinduced intracellular controlled release drug delivery in human cells by gold-capped mesoporous silica nanosphere. , 2009, Journal of the American Chemical Society.

[21]  Niveen M. Khashab,et al.  Light-operated mechanized nanoparticles. , 2009, Journal of the American Chemical Society.

[22]  Benjamin Gilbert,et al.  Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. , 2008, ACS nano.

[23]  J. F. Stoddart,et al.  pH-responsive supramolecular nanovalves based on cucurbit[6]uril pseudorotaxanes. , 2008, Angewandte Chemie.

[24]  William R. Dichtel,et al.  Enzyme-responsive snap-top covered silica nanocontainers. , 2008, Journal of the American Chemical Society.

[25]  R. Martínez‐Máñez,et al.  Dual aperture control on pH- and anion-driven supramolecular nanoscopic hybrid gate-like ensembles. , 2008, Journal of the American Chemical Society.

[26]  J. Karp,et al.  Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .

[27]  B. Kristal,et al.  Zinc Irreversibly Damages Major Enzymes of Energy Production and Antioxidant Defense Prior to Mitochondrial Permeability Transition* , 2007, Journal of Biological Chemistry.

[28]  K. Kröncke.  Cellular stress and intracellular zinc dyshomeostasis. , 2007, Archives of biochemistry and biophysics.

[29]  Shashi K Murthy,et al.  Nanoparticles in modern medicine: State of the art and future challenges , 2007, International journal of nanomedicine.

[30]  Brian G. Trewyn,et al.  Mesoporous Silica Nanoparticles for Drug Delivery and Biosensing Applications , 2007 .

[31]  Sang Cheon Lee,et al.  Controlled release of guest molecules from mesoporous silica particles based on a pH-responsive polypseudorotaxane motif. , 2007, Angewandte Chemie.

[32]  Ruth Duncan,et al.  Polymer conjugates as anticancer nanomedicines , 2006, Nature Reviews Cancer.

[33]  María J Vicent,et al.  Polymer conjugates: nanosized medicines for treating cancer. , 2006, Trends in biotechnology.

[34]  Victor S-Y Lin,et al.  Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. , 2005, Angewandte Chemie.

[35]  M. Ferrari.  Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.

[36]  V. Torchilin.  Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[37]  J. Fréchet,et al.  Dendrimers and dendritic polymers in drug delivery. , 2005, Drug discovery today.

[38]  Ramón Martínez-Máñez,et al.  Toward the development of ionically controlled nanoscopic molecular gates. , 2004, Journal of the American Chemical Society.

[39]  Victor S-Y Lin,et al.  A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. , 2003, Journal of the American Chemical Society.

[40]  Masahiro Fujiwara,et al.  Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica , 2003, Nature.

[41]  K. Edwards,et al.  Formation of transition metal-doxorubicin complexes inside liposomes. , 2002, Biochimica et biophysica acta.

[42]  H. Kozłowski,et al.  How Fe3+ binds anthracycline antitumour compounds. The myth and the reality of a chemical sphinx. , 1999, Journal of inorganic biochemistry.

[43]  H. Popper,et al.  MECHANISM OF COLLAGEN RESORPTION IN REVERSIBLE HEPATIC FIBROSIS. , 1964, Experimental and molecular pathology.